• 1
    Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 15291533.
  • 2
    Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YHW. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cell. J Virol 1993; 67: 58235832.
  • 3
    Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 10481053.
  • 4
    Sheen IS, Liaw YF, Lin DY, Chu CM. Role of hepatitis C and Delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994; 170: 358361.
  • 5
    Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. HEPATOLOGY 1995; 22: 11011108.
  • 6
    Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28: 2733.
  • 7
    Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, et al. Virological and clinical aspects of reciprocal inhibitory effect of hepatitis B, C, and Delta viruses in patients with chronic hepatitis. HEPATOLOGY 2000; 32: 11061110.
  • 8
    Saitta C, Pontisso P, Brunetto MR, Fargion S, Gaeta GB, Niro GA, et al. Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy. Antivir Ther 2006; 11: 931934.
  • 9
    Coppola N, Pisapia R, Tonziello G, Martini S, Imparato M, Piai G, et al. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection. Antivir Ther 2008; 13: 307318.
  • 10
    Chu CM, Liaw YF. Simultaneous acute hepatitis B virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C. Clin Infect Dis 1995; 20: 703705.
  • 11
    Coppola N, Marrocco C, Di Caprio D, Coviello G, Scolastico C, Filippini P, et al. Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases. Clin Infect Dis 2003; 36: 528532.
  • 12
    Chu CM, Yeh CT, Liaw YT. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut 1999; 45: 613617.
  • 13
    Chu CM, Yeh CT, Liaw YT. Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis. J Clin Microbiol 1999; 37: 235237.
  • 14
    Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004; 126: 10241029.
  • 15
    Sagnelli E, Coppola N, Marrocco C, Onofrio M, Sagnelli C, Coviello G, et al. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course. J Clin Virol 2006; 35: 317320.
  • 16
    Wietzke P, Schott P, Braun F, Mihm S, Ramadori G. Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver 1999; 19: 348353.
  • 17
    Liaw YF, Yeh CT, Tsai SL. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 2000; 95: 29782980.
    Direct Link:
  • 18
    Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, et al. HBV superinfection in HCV chronic carriers, viral interaction and clinical course. HEPATOLOGY 2002; 36: 12851291.
  • 19
    Fujiwara K, Yokosuka O, Ehata T, Saisho H, Saotome N, Suzuki K, et al. Association between severity of type A hepatitis and nucleotide variations in the 5' non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions. Gut 2002; 51: 8288.
  • 20
    Ozaza A, Tanaka Y, Orito E, Sugiyama M, Kang JH, Hige S, et al. Influence of genotype and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. HEPATOLOGY 2006; 44: 326334.
  • 21
    Lee WM. Liver failure and liver support. Semin Liver Dis 2008; 28: 135136.
  • 22
    Aliyu SH, Aliyu MH, Salihu HM, Parmar S, Jalal H, Curran MD. Rapid detection and quantitation of hepatitis B virus DNA by real-time PCR using a new fluorescent (FRET) detection system. J Clin Virol 2004; 30: 191195.
  • 23
    Kessler HH, Stelzl E, Daghofer E, Santner BI, Marth E, Lackner H, et al. Semiautomated quantification of hepatitis B virus DNA in a routine diagnostic laboratory. Clin Diagn Lab Immunol 2000; 7: 853855.
  • 24
    Shyamala V, Contrell J, Madriaga D, Arcangel P, Hartman M, Gasuad K, et al. Quantitation of commercially available nucleic acid amplification run controls and standards by target-capture PCR based assay. Transfusion 2004; 44: SP201, p91A.
  • 25
    Ratge D, Scheiblhuber B, Nitsche M, Knabbe C. High-speed detection of blood-borne hepatitis C virus RNA by single-tube real-time fluorescence reverse-transcription PCR with LightCycler. Clin Chem 2000; 46: 19871989.
  • 26
    Gruener NH, Jung MC, Ulsenheimer A, Gerlach TJ, Diepolder HM, Schirren CA, et al. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. J Hepatol 2002; 37: 866869.
  • 27
    Deterding K, Pothakamuri SV, Schlaphoff V, Hadem J, Metzler F, Bahr MJ, et al. Clearance of chronic HCV infection during acute Delta hepatitis. Infection 2007; doi:10.1007/s15010-007-7204-7.
  • 28
    Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 6591.
  • 29
    Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194: 13951406.
  • 30
    Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001; 75: 85168523.
  • 31
    Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 2001; 82: 723733.
  • 32
    Sagnelli E, Coppola N, Pisaturo M, Pisapia R, Onofrio M, Sagnelli C, et al. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Clin Infect Dis 2006; 42: 15361543.
  • 33
    Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Böker KH, et al. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. J Hepatol 2006; 45: 770778.
  • 34
    Wietzke-Braun P, Mänhardt LB, Rosenberger A, Uy A, Ramadori G, Mihm S. Spontaneous elimination of hepatitis C infection: a retrospective study on demographic, clinical and serological correlates. World J Gastroenterol 2007; 13: 42244229.
  • 35
    Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. HEPATOLOGY 2006; 1: 99106.
  • 36
    NIH consensus development conference targets prevention and management of hepatitis C. Am Fam Physician 1997; 56: 959961.
  • 37
    Consensus Panel: EASL international Consensus Conference on hepatitis C. J Hepatol 1999; 31(Suppl 1): S3S8.
  • 38
    Jakiche R, Borrego ME, Raisch DW, Gupchup GV, Pai MA, Jakiche A. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses. Am J Med Sci 2007; 333: 2634.